GillermanRGBrowningRA. Drug use inefficiency: a hidden source of wasted health care dollars. Anesth Analg2000; 91: 921–924.
2.
BachPBContiRMMullerRJet al.Overspending driven by oversized single dose vials of cancer drugs. BMJ2016; 352: i788–i788.
3.
LienKCheungMCChanKKW. Adjusting for drug wastage in economic valuations of new therapies for hematologic malignancies: a systematic review. J Oncol Pract2016; 12: e369–e379.
4.
IwamotoT. Drug vial optimization(DVO) for anti-cancer drugs. Gan To Kagaku Ryoho2017; 44: 353–356.
5.
SmithRSV. A 2-year retrospective review of vial sharing options for the compounding of cytotoxics. Eur J Hosp Pharm2015; 22: 161–164.
6.
GilbarPJChambersCRGilbarEC. Opportunities to significantly reduce expenditure associated with cancer drugs. Future Oncol2017; 13: 1311–1322.
7.
Gilbar PJ and Chambers CR. How can we ensure value for money from expenditure on injectable cancer drugs? J Oncol Pharm Pract. Epub ahead of print 29 April 2017. DOI: 10.1177/10781552177706195.
8.
FasolaGAprileGMariniLet al.Drug waste minimisation as an effective strategy of cost-containment in oncology. BMC Health Serv Res2014; 14: 57–57.
9.
Gilbar PJ, Chambers CR, Vandenbrouche J, et al. How can the use of closed system transfer devices to facilitate sharing of drug vials be optimised to achieve maximum cost savings? J Oncol Pharm Pract. Epub ahead of print 29 January 2018. DOI: 10.1177/1078155217753980.
10.
DooleyMJSinghSMichaelM. Implications of dose rounding of chemotherapy to the nearest vial size. Support Care Cancer2004; 12: 653–656.
11.
Chillari KA, Southward J and Harrigan N. Assessment of the potential impact of dose rounding parenteral chemotherapy agents on cost savings and drug waste minimization. J Oncol Pharm Pract. Epub ahead of print 21 July 2017. DOI: 10.1177/1078155217722205.
12.
ChatelutEWhite-KoningMLMathijssenRHJet al.Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents. Br J Cancer2012; 107: 1100–1106.
